René Muttenzer

Nessuna posizione attualmente

81 anni

Health Technology

Consumer Services

Profilo

Dr. René Muttenzer is on the Board of Directors at Polyphor AG and Molecular Health AG.
Dr. Muttenzer was previously employed as a Principal by Novartis AG.
He also served on the board at Acino Holding AG.
He received his graduate degree from the University of Basel.

Precedenti posizioni note di René Muttenzer

Società	Posizione	Fine
ACINO HOLDING AG	Direttore/Membro del Consiglio	31/03/2012
NOVARTIS AG	Corporate Officer/Principal	-
Posbelduf Biotech AG Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland.	Direttore/Membro del Consiglio	-
SPEXIS AG	Direttore/Membro del Consiglio	-

Vedi nel dettaglio l'esperienza di René Muttenzer

Formazione di René Muttenzer

University of Basel

Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di René Muttenzer

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
SPEXIS AG	Health Technology
NOVARTIS AG	Health Technology

Aziende private	2
Acino International AG Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland.	Health Technology
Posbelduf Biotech AG Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland.	Health Technology